Chewable tablets Maltofer FOL are applied to treatment of deficiency of iron without anemia (latent deficiency of iron) and an iron deficiency anemia (clinically apparent deficiency of iron). The deficiency of iron and its degree have to be confirmed by the corresponding laboratory researches.

Structure

Active ingredient:

1 tablet contains 357 mg of iron (III) hydroxide polimaltozat that is equivalent to 100 mg of iron, folic acid of 0.35 mg;

Excipients: microcrystalline cellulose, cocoa powder, sodium cyclomate, polyethyleneglycol 6000, talc, vanillin, dekstrakta, fragrance chocolate.

Contraindication

• hypersensitivity or intolerance of active ingredient or any component of medicine is available;
• excess content of iron in an organism (for example hemochromatosis, a hemosiderosis);
• frustration of mechanisms of removal of iron (lead anemia, sideroakhrestichesky anemia, thalassemia);
• anemia, not caused by deficiency of iron (for example hemolytic anemia, the megaloblastny anemia caused by insufficiency of B12 vitamin);
• stenosis of a gullet and/or other obstructive diseases of a digestive tract; intestines diverticulum, intestinal impassability, regular hemotransfusions;
• simultaneous application of parenteral forms of iron.

Route of administration

Drug Maltofer Fol, chewable tablets, it is necessary to accept in time or right after food. It is possible to swallow of tablets entirely.

Feature of application

Pregnant

Should use with care medicament during pregnancy.

Corresponding researches were not conducted by

.

Overdose

Against the background of administration of medicament Maltofer FOL in case of overdose it was not recorded either symptoms of intoxication, or excessive intake of iron in an organism in connection with features of controlled discharge and hypotoxicity of a polymaltose complex of ferrous hydroxide (ІІІ) (LD ₅₀ at mice and rats> 2000 mg of iron/kg of body weight). About cases of inadvertent overdose with a lethal outcome it was not reported.

Side effects

Most frequent side reaction is discoloration the calla (at 23% of patients) caused by an iron conclusion.

by

as this application inhibits absorption of iron preparations for oral administration. Iron preparations for parenteral administration can be used in case treatment by oral medicines is not acceptable.

Storage conditions

to Store

at a temperature not above 25 °C, in the inaccessible for children and protected from light place.

Expiration date - 5 years.